scPharmaceuticals Inc (SCPH)
4.825
+0.26
(+5.58%)
USD |
NASDAQ |
May 16, 16:00
4.83
0.00 (0.00%)
After-Hours: 20:00
scPharmaceuticals Cash from Investing (Quarterly): 29.32M for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 29.32M |
| December 31, 2023 | 26.46M |
| September 30, 2023 | -22.92M |
| June 30, 2023 | 9.427M |
| March 31, 2023 | 7.00M |
| December 31, 2022 | -42.99M |
| September 30, 2022 | 10.78M |
| June 30, 2022 | -0.861M |
| March 31, 2022 | -12.79M |
| December 31, 2021 | 4.501M |
| September 30, 2021 | 9.521M |
| June 30, 2021 | 5.403M |
| March 31, 2021 | 12.70M |
| December 31, 2020 | 36.70M |
| Date | Value |
|---|---|
| September 30, 2020 | -29.69M |
| June 30, 2020 | -40.47M |
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | |
| December 31, 2018 | 0.041M |
| September 30, 2018 | 0.00 |
| June 30, 2018 | -0.041M |
| March 31, 2018 | |
| December 31, 2017 | -0.004M |
| September 30, 2017 | -0.178M |
| June 30, 2017 | -0.012M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-42.99M
Minimum
Dec 2022
36.70M
Maximum
Dec 2020
0.1048M
Average
2.250M
Median
Cash from Investing (Quarterly) Benchmarks
| Anika Therapeutics Inc | -1.808M |
| Spero Therapeutics Inc | 0.00 |
| electroCore Inc | -- |
| NovaBay Pharmaceuticals Inc | 1.068M |
| Palatin Technologies Inc | 9.462M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -17.70M |
| Cash from Financing (Quarterly) | 0.015M |
| Free Cash Flow | -60.45M |
| Free Cash Flow Per Share (Quarterly) | -0.4544 |
| Free Cash Flow to Equity (Quarterly) | -18.28M |
| Free Cash Flow Yield | -32.29% |